Reference
Paul, M. M., Dannhäuser, S., Morris, L., Mrestani, A., Hübsch, M., Gehring, J., ... & Langenhan, T. (2022). The human cognition-enhancing CORD7 mutation increases active zone number and synaptic release. Brain, 145(11), 3787-3802. https://doi.org/10.1093/brain/awac011
Review
In a recent study published in Brain, Paul et al. (2022) delved into the enigmatic CORD7 mutation, which is associated with increased verbal IQ and working memory in humans. The autosomal dominant syndrome results from the R844H exchange in the C2A domain of RIMS1/RIM1, a vital component of presynaptic active zones. Until now, the impact of the CORD7 mutation on synaptic function remained unclear.
Using Drosophila melanogaster as a disease model, the researchers employed protein expression and X-ray crystallography to resolve the molecular structure of the fly's C2A domain. They found that the location of the CORD7 mutation is structurally conserved in fly RIM. CRISPR/Cas9-assisted genomic engineering was then utilized to generate rim alleles encoding the R915H CORD7 exchange or R915E, R916E substitutions to investigate their effects on synaptic transmission.
Electrophysiological characterization revealed that the CORD7 mutation exerted a semi-dominant effect on synaptic transmission, resulting in the faster, more efficient synaptic release, increased size of the readily releasable pool, and decreased sensitivity for the fast calcium chelator BAPTA. Additionally, the rim CORD7 allele increased the number of presynaptic active zones without altering their nanoscopic organization, as demonstrated by super-resolution microscopy of the presynaptic scaffold protein Bruchpilot/ELKS/CAST.
These findings suggest that the CORD7 mutation enhances synaptic transmission efficiency by promoting tighter release coupling, an increased readily releasable pool size, and more release sites. The authors conclude that similar mechanisms may underlie the CORD7 disease phenotype in patients and contribute to their heightened cognitive abilities. This study not only provides valuable insights into the molecular underpinnings of the CORD7 mutation but also paves the way for further research into potential therapeutic applications.